Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Bio-Rad Reports Third-Quarter 2015 Financial Results
November 3, 2015 4:15 PM ESTHERCULES, CA -- (Marketwired) -- 11/03/15 -- Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, announced financial results today for the third quarter ended September 30, 2015.
Third-quarter reported revenues were $470.0 million, a decrease of 11.4% compared to $530.6 million reported for the third quarter of 2014. On a currency-neutral basis, quarterly revenues decreased 2.2% compared to the same period last year. Third-quarter gross margin increased to 56.1% compared to 54.4% during the same quarter in 2014. The year-over-year increase in gross... More



